Cargando…

Plasmalogens Inhibit APP Processing by Directly Affecting γ-Secretase Activity in Alzheimer's Disease

Lipids play an important role as risk or protective factors in Alzheimer's disease (AD). Previously it has been shown that plasmalogens, the major brain phospholipids, are altered in AD. However, it remained unclear whether plasmalogens themselves are able to modulate amyloid precursor protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rothhaar, Tatjana L., Grösgen, Sven, Haupenthal, Viola J., Burg, Verena K., Hundsdörfer, Benjamin, Mett, Janine, Riemenschneider, Matthias, Grimm, Heike S., Hartmann, Tobias, Grimm, Marcus O. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific World Journal 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322458/ https://www.ncbi.nlm.nih.gov/pubmed/22547976 http://dx.doi.org/10.1100/2012/141240

Ejemplares similares

Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)

APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression
por: Grimm, Marcus O. W., et al.
Publicado: (2015)

Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2011)

Amyloid Precursor Protein (APP) Mediated Regulation of Ganglioside Homeostasis Linking Alzheimer's Disease Pathology with Ganglioside Metabolism
por: Grimm, Marcus O. W., et al.
Publicado: (2012)

Upregulation of PGC-1α expression by Alzheimer’s disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP
por: Robinson, Ari, et al.
Publicado: (2014)

Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)

APP Function and Lipids: A Bidirectional Link
por: Grimm, Marcus O. W., et al.
Publicado: (2017)

The impact of capsaicinoids on APP processing in Alzheimer’s disease in SH-SY5Y cells
por: Grimm, Marcus O. W., et al.
Publicado: (2020)

The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2016)

γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not
por: Lessard, Christian B., et al.
Publicado: (2020)

Regulatory feedback cycle of the insulin‐degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer’s disease
por: Lauer, Anna A., et al.
Publicado: (2020)

γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022)

Enzyme–substrate interface targeting by imidazole‐based γ‐secretase modulators activates γ‐secretase and stabilizes its interaction with APP
por: Petit, Dieter, et al.
Publicado: (2022)

γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP)
por: Lessard, Christian B., et al.
Publicado: (2015)

Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer’s Disease
por: Hung, Christy O.Y., et al.
Publicado: (2018)

A γ-Secretase Inhibitor, but Not a γ-Secretase Modulator, Induced Defects in BDNF Axonal Trafficking and Signaling: Evidence for a Role for APP
por: Weissmiller, April M., et al.
Publicado: (2015)

Impact of Vitamin D(3) Deficiency on Phosphatidylcholine-/Ethanolamine, Plasmalogen-, Lyso-Phosphatidylcholine-/Ethanolamine, Carnitine- and Triacyl Glyceride-Homeostasis in Neuroblastoma Cells and Murine Brain
por: Lauer, Anna Andrea, et al.
Publicado: (2021)

Acetylcholinesterase blocks cleavage of APP by γ-secretase in 293 cells and mouse brain
por: Niu, Xin, et al.
Publicado: (2012)

Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
por: Mousa, Youssef M., et al.
Publicado: (2020)

Dietary plasmalogen increases erythrocyte membrane plasmalogen in rats
por: Mawatari, Shiro, et al.
Publicado: (2012)

Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme
por: Mett, Janine, et al.
Publicado: (2021)

Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site
por: Uemura, Kengo, et al.
Publicado: (2010)

Independent Relationship between Amyloid Precursor Protein (APP) Dimerization and γ-Secretase Processivity
por: Jung, Joo In, et al.
Publicado: (2014)

Plasmalogens and Alzheimer’s disease: a review
por: Su, Xiao Q., et al.
Publicado: (2019)

The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
por: Chávez-Gutiérrez, Lucía, et al.
Publicado: (2012)

Turning the tide on Alzheimer’s disease: modulation of γ-secretase
por: Luo, Joanna E., et al.
Publicado: (2022)

Presenilin/γ-Secretase and Inflammation
por: Saura, Carlos A.
Publicado: (2010)

Time-Dependent Analysis of Plasmalogens in the Hippocampus of an Alzheimer’s Disease Mouse Model: A Role of Ethanolamine Plasmalogen
por: Azad, Abul Kalam, et al.
Publicado: (2021)

Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2016)

α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP
por: Roberts, Hazel L., et al.
Publicado: (2017)

Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
por: Mousa, Youssef M., et al.
Publicado: (2020)

γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing
por: Weber, Tobias A., et al.
Publicado: (2021)

Plasmalogen Replacement Therapy
por: Bozelli, José Carlos, et al.
Publicado: (2021)

γ-Secretase Pharmacology: What Pharmacology Will Work for Alzheimer's Disease?
por: Toyn, Jeremy H., et al.
Publicado: (2013)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
por: Maia, Miguel A., et al.
Publicado: (2019)

A promising new γ-secretase modulator for Alzheimer’s disease
por: Dobrowolska Zakaria, Justyna A., et al.
Publicado: (2021)

Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer’s Disease
por: Wolfe, Michael S.
Publicado: (2021)

Plasmalogen biosynthesis is spatiotemporally regulated by sensing plasmalogens in the inner leaflet of plasma membranes
por: Honsho, Masanori, et al.
Publicado: (2017)

Structure-function relationship of γ-secretase
por: Tomita, Taisuke
Publicado: (2012)

The dynamic conformational landscape of γ-secretase
por: Elad, Nadav, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iss8t9j3qh9sdacjavt25squqh